Merck KGaA, Darmstadt, Germany announced several research grants and challenges during the company’s 350^th anniversary – in addition to already existing initiatives. The new research grants and challenges are mainly directed to scientists working in institutes, universities or start-up companies around the world.

“The best innovation for patients and customers is generated when people from different disciplines or backgrounds work closely together. Therefore, we are constantly looking for new ways of connecting scientists, entrepreneurs and experts from various fields to find new solutions for today’s technological and scientific challenges,” said Isabel De Paoli, chief Strategy Officer at Merck KGaA, Darmstadt, Germany. “As a company that has been based on science and technology for 350 years, we not only think ahead but also engage with external researchers across the world to imagine the next 350 years in science and technology together.”

Merck KGaA, Darmstadt, Germany aims to stimulate open innovation processes in the three areas of healthcare, life science and performance materials. Merck KGaA, Darmstadt, Germany, intends to provide several research grants of up to €350,000 per year for three years in various research areas with the option of extension or expansion.

Deadline for handing in applications is August 15, 2018. More information on the process can also be found here.

These research initiatives in connection with the 350^th anniversary of Merck KGaA, Darmstadt, Germany, are complemented by a broad range of already existing awards and initiatives for the scientific community. Most of the initiatives regarding Healthcare and Performance Materials topics are bundled here, whereas research initiatives connected to Life Science topics can be found here. The initiatives comprise challenges in oncology, fertility, displays, and synthetic organic chemistry for example the Alfred R. Bader award.